200 related articles for article (PubMed ID: 28223148)
1. STAT3 activation in infection and infection-associated cancer.
Lu R; Zhang YG; Sun J
Mol Cell Endocrinol; 2017 Aug; 451():80-87. PubMed ID: 28223148
[TBL] [Abstract][Full Text] [Related]
2. Taming the elephant: Salmonella biology, pathogenesis, and prevention.
Andrews-Polymenis HL; Bäumler AJ; McCormick BA; Fang FC
Infect Immun; 2010 Jun; 78(6):2356-69. PubMed ID: 20385760
[TBL] [Abstract][Full Text] [Related]
3. Viral manipulation of STAT3: Evade, exploit, and injure.
Roca Suarez AA; Van Renne N; Baumert TF; Lupberger J
PLoS Pathog; 2018 Mar; 14(3):e1006839. PubMed ID: 29543893
[TBL] [Abstract][Full Text] [Related]
4. Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
Johnson DE; O'Keefe RA; Grandis JR
Nat Rev Clin Oncol; 2018 Apr; 15(4):234-248. PubMed ID: 29405201
[TBL] [Abstract][Full Text] [Related]
5. The potential and controversy of targeting STAT family members in cancer.
Verhoeven Y; Tilborghs S; Jacobs J; De Waele J; Quatannens D; Deben C; Prenen H; Pauwels P; Trinh XB; Wouters A; Smits ELJ; Lardon F; van Dam PA
Semin Cancer Biol; 2020 Feb; 60():41-56. PubMed ID: 31605750
[TBL] [Abstract][Full Text] [Related]
6. STAT3: A Potential Drug Target for Tumor and Inflammation.
Hu YS; Han X; Liu XH
Curr Top Med Chem; 2019; 19(15):1305-1317. PubMed ID: 31218960
[TBL] [Abstract][Full Text] [Related]
7. Highlighted STAT3 as a potential drug target for cancer therapy.
Lee H; Jeong AJ; Ye SK
BMB Rep; 2019 Jul; 52(7):415-423. PubMed ID: 31186087
[TBL] [Abstract][Full Text] [Related]
8. STAT3: a multifaceted oncoprotein.
Guanizo AC; Fernando CD; Garama DJ; Gough DJ
Growth Factors; 2018 Apr; 36(1-2):1-14. PubMed ID: 29873274
[TBL] [Abstract][Full Text] [Related]
9. Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A; Wagner C; de Araujo ED; Bajusz D; Neubauer HA; Herling M; Gunning PT; Keserű GM; Moriggl R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817042
[TBL] [Abstract][Full Text] [Related]
10. Novel activators and small-molecule inhibitors of STAT3 in cancer.
Yang L; Lin S; Xu L; Lin J; Zhao C; Huang X
Cytokine Growth Factor Rev; 2019 Oct; 49():10-22. PubMed ID: 31677966
[TBL] [Abstract][Full Text] [Related]
11. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma.
Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z
J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355
[TBL] [Abstract][Full Text] [Related]
12. STAT3, stem cells, cancer stem cells and p63.
Galoczova M; Coates P; Vojtesek B
Cell Mol Biol Lett; 2018; 23():12. PubMed ID: 29588647
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.
Kitamura H; Ohno Y; Toyoshima Y; Ohtake J; Homma S; Kawamura H; Takahashi N; Taketomi A
Cancer Sci; 2017 Oct; 108(10):1947-1952. PubMed ID: 28749573
[TBL] [Abstract][Full Text] [Related]
14. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
15. Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?
Jaśkiewicz A; Domoradzki T; Pająk B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158194
[TBL] [Abstract][Full Text] [Related]
16. JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation.
Gotthardt D; Trifinopoulos J; Sexl V; Putz EM
Front Immunol; 2019; 10():2590. PubMed ID: 31781102
[TBL] [Abstract][Full Text] [Related]
17. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases.
Gao Y; Zhao H; Wang P; Wang J; Zou L
Scand J Immunol; 2018 Dec; 88(6):e12727. PubMed ID: 30341772
[TBL] [Abstract][Full Text] [Related]
18. Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review).
Zhang G; Hou S; Li S; Wang Y; Cui W
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38488027
[TBL] [Abstract][Full Text] [Related]
19. CCL5 promotes the proliferation and metastasis of bladder cancer via the JAK2/STAT3 signaling pathway.
Shen J; Chen C; Chen Z; Gong P; Lee LS; Schmeusser BN; Zhuang Q; Sun Y; Xue D; He X
Transl Androl Urol; 2023 Dec; 12(12):1845-1858. PubMed ID: 38196701
[TBL] [Abstract][Full Text] [Related]
20. Serial KinderMiner (SKiM) discovers and annotates biomedical knowledge using co-occurrence and transformer models.
Millikin RJ; Raja K; Steill J; Lock C; Tu X; Ross I; Tsoi LC; Kuusisto F; Ni Z; Livny M; Bockelman B; Thomson J; Stewart R
BMC Bioinformatics; 2023 Nov; 24(1):412. PubMed ID: 37915001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
